RNS
Number: 6585R
ITV PLC
7 June 2024
7 June
2024
ITV PLC
PUBLICATION OF SUPPLEMENT TO
PROSPECTUS
ITV Plc (the "Company") today announces, regarding
the Company's €3,000,000,000 Euro Medium Term Note Programme (the
"Programme"), they have
published a supplement (the "Supplement") to the base prospectus
dated 28 March 2024 in respect of the Programme (the "Prospectus"). The Supplement has been
approved by the Financial Conduct Authority and is available for
viewing.
The Supplement should be read and
construed in conjunction with the Prospectus.
To view the Supplement, please paste the
following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/6585R_1-2024-6-7.pdf
The Supplement will also be available for
viewing at the National Storage Mechanism and will shortly be
available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Group Secretariat
ITV Plc
White City Place
201 Wood Lane
London
W12 7RU
groupsecretariat@itv.com
For general enquiries, please contact Investor
Relations:
Pippa
Foulds
+44 7778 031097
Faye Dipnarine
+44 2071 576581
LEI for ITV plc:
ZLECI7ED2QMWFGYCXZ59
Website: www.itv.com; investor
information: www.itvplc.com
DISCLAIMER -
INTENDED ADDRESSEES
EU MiFID II professionals/ECPs only/No EEA
PRIIPs KID
UK MiFIR professionals/ECPs only/No UK PRIIPs
KID
Please note that the information contained in
the Prospectus, as supplemented (the "Supplemented Prospectus") may be
addressed to and/or targeted at persons who are residents of
particular countries (as specified in the Supplemented Prospectus)
only and is not intended for use and should not be relied upon by
any person outside these countries and/or to whom the offer
contained in the Supplemented Prospectus is not addressed. Prior to
relying on the information contained in the Supplemented
Prospectus, you must ascertain from the Supplemented Prospectus
whether or not you are part of the intended addressees of the
information contained therein.
In particular, neither this announcement nor
the Supplemented Prospectus shall constitute an offer to sell or
the solicitation of an offer to buy securities in the United States
or in any other jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration, exemption from
registration or qualification under the securities law of any such
jurisdiction.
The Notes have not been, and will not be,
registered under the United States Securities Act of 1933, as
amended (the "Securities
Act"), or under the securities laws of any state or other
jurisdiction of the United States, and the Notes may not be
offered, sold, pledged, taken up, resold, transferred or delivered,
directly or indirectly, in the United States or to, or for the
account or benefit of, U.S. persons (as defined in Regulation S
under the Securities Act ("Regulation S")) unless the Notes are
registered under the Securities Act or an exemption from the
registration requirements for the Securities Act is available. The
Notes are being offered and sold only to non-U.S. persons outside
the United States in reliance upon Regulation S. The Supplemented
Prospectus may not be accessed from, or transmitted in or into, the
United States.
Your right to access this service is
conditional upon complying with the above requirements.